Durlobactam (sodium)
Durlobactam sodium salt (ETX2514) is a broad-spectrum β-lactamase inhibitor with IC50s of 4, 14 and 190 nM for Class A KPC-2, Class C AmpC and Class D OXA-24, respectively. For the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii[1].
Product Specifications
CAS Number
[1467157-21-6]
Product Name Alternative
ETX2514
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Durlobactam_sodium_salt.html
Purity
99.62
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
NC([C@H]1[N@@]2C(N([C@H](C=C1C)C2)OS(=O)(O[Na])=O)=O)=O
Molecular Formula
C8H10N3NaO6S
Molecular Weight
299.24
References & Citations
Acinetobacter baumannii
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
217310 25 mg
Dafadine-A ((5- ((2,6-Dimethylphenoxy) methyl) isoxazol-3-yl) (4- (pyridin-4-yl) piperidin-1-yl) methanone, 4- (1- ((5- ((2,6-Dimethylphenoxy) methyl) -3-isoxazolyl) carbonyl) -4-piperidinyl) pyridine, DAF-9 Cytochrome P450 Inhibitor, Dafadine-A) discontinued
Ask
View Details 
